Biomedical Engineering Reference
In-Depth Information
34. Zwaal, R.F.A., Comfurius, P., and Bevers, E.M., Lipid-protein interactions in blood coagulation,
Bioch.
Biophys. Acta
, 1376, 433, 1998.
35. Dahlback, B., Blood coagulation,
Lancet
, 355, 1627, 2000.
36. Damus, P.S., Hicks, M., and Rosenberg, R.D., Anticoagulant action of heparin,
Nature
, 246, 355, 1973.
37. Petitou, M., Casu, B., and Lindahl, U., 1976-1983, a critical period in the history of heparin: the discov-
ery of the antithrombin binding site,
Biochimie
, 85, 83, 2003.
38. Eldor, A., Orevi, M., and Rigbi, M., The role of the leech in medical therapeutics,
Haemostasis
, 10, 201,
1996.
39. Dahlback, B. and Villoutreix, B.O., The anticoagulant protein C pathway,
FEBS Lett.
, 579, 3310, 2005.
40. Dahlback, B. and Villoutreix, B.O., Regulation of blood coagulation by the protein C anticoagulant
pathway: novel insights into structure-function relationships and molecular recognition,
Arterioscerl.
Thromb. Vasc. Biol.
, 25, 1311, 2005.
41. Tans, G., Nicolaes, G.A., and Rosing, J., Regulation of thrombin formation by activated protein C: effect
of the factor V Leiden mutation,
Semin. Hematol.
, 34, 244, 1997.
42. Rosing, J. et al., Low-dose oral contraceptives and acquired resistance to activated protein C: a random-
ized cross-over study,
Lancet
, 354, 2036, 1999.
43. Kaplan, A.P. and Silverberg, M., The coagulation-kinin pathway of human plasma,
Blood
, 70, 1, 1987.
44. Klinge J. et al., Hemophilia A: from basic science to clinical practice,
Semin. Thromb. Hemost.
, 28, 309,
2002.
45. Peyvandi, F. et al., Rare coagulation defi ciencies, Haemophilia, 8, 308, 2002.
46. Steffel, J., Luscher, T.F., and Tanner, F.C., Tissue factor in cardiovascular diseases,
Circulation
, 113,
722, 2006.
47. Lwaleed, B.A. and Bass, P.S., Tissue factor pathway inhibitor: structure, biology and involvement in
disease,
J. Pathol.
, 208, 327, 2006.
48. Zwaal, R.F.A., Comfurius, P., and Bevers, E.M., Surface exposure of phosphatidylserine in pathological
cells,
Cell. Mol. Life Sci.
, 62, 971, 2005.
49. Rand, M.L., Leung, R., and Packham, M.A., Platelet function assays,
Transf. Apheresis Sci.
, 28, 307,
2003.
50. Ko, T., Lin, J., and Cooper, S.L., Surface characterization and platelet adhesion studies of plasma-
sulphonated polyethylene,
Biomaterials
, 14, 657, 1993.
51. Heijnen, H.F.G. et al., Activated platelets release two types of membrane vesicles: microvesicles by
surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules,
Blood
, 94, 3791, 1999.
52. Nomura S., Function and clinical signifi cance of platelet-derived microparticles,
Int. J. Hematol.
, 74,
397, 2001.
53. Tan, K.T. and Lip, G.Y.H., The potential role of platelet microparticles in atherosclerosis,
Thromb. Hae-
most.
, 94, 488, 2005.
54. Janatova, J., Activation and control of complement, infl ammation, and infection associated with the use
of biomedical polymers,
ASAIO J.
, 46, S53, 2000.
55. Anderson, J.M., Biological responses to materials,
Ann. Rev. Mater. Res.
, 31, 81, 2001.
56. Kappelmayer, J. et al., Tissue factor is expressed on monocytes during simulated extracorporal circula-
tion,
Circ. Res.
, 72, 1075, 1993.
57. Tabuchi, N. et al., activated leukocytes adsorbed on the surface of an extracorporal circuit,
Artif. Organs
,
27, 591, 2003.
58. Xue, L. and Greisler, H.P., Biomaterials in the development and future of vascular grafts,
J. Vasc. Surg.
,
37, 472, 2003.
59. Ratner, B.D. and Bryant, S.J., Biomaterials: where we have been and where we are going,
Ann. Rev.
Biomed. Eng.
, 6, 41, 2004.
60. Lau, H. and Cheng, S.W., Is the preferential use of ePTFE grafts in femorofemoral bypass justifi ed?
Ann. Vasc. Surg.
, 15, 383, 2001.
61. Bordenave L. et al.,
In vitro
endothelialized ePTFE prostheses: clinical update 20 years after the fi rst
realization,
Clin. Hemorheol. Microcirc.
, 33, 227, 2005.
62. Kannan, R.Y. et al., Current status of prosthetic bypass grafts: a review,
J. Biomed. Mater. Res.
, 74B,
570, 2005.
63. Tiwari, A. et al., New prostheses for use in bypass grafts with special emphasis of polyurethanes,
Cardiovasc. Surg.
, 10, 191, 2002.
